+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "C Reactive Protein Test"

Point of Care Lipid Test Market by Product Type, Application, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Point of Care Lipid Test Market by Product Type, Application, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • December 2022
  • 375 Pages
  • Global
From
C-Reactive Protein Testing Market by Assay Type (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others) and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030 - Product Thumbnail Image

C-Reactive Protein Testing Market by Assay Type (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others) and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • Report
  • February 2022
  • 229 Pages
  • Global
From
Loading Indicator

The C Reactive Protein Test is a type of In Vitro Diagnostics (IVD) test used to detect inflammation in the body. It is a blood test that measures the amount of C-reactive protein (CRP) in the blood. CRP is a protein produced by the liver in response to inflammation. High levels of CRP in the blood can indicate an infection or other inflammatory condition. The C Reactive Protein Test is used to diagnose and monitor a variety of conditions, including rheumatoid arthritis, lupus, and inflammatory bowel disease. It is also used to monitor the effectiveness of treatments for these conditions. The C Reactive Protein Test market is a growing segment of the IVD market. It is used in both clinical and research settings, and is becoming increasingly popular due to its accuracy and ease of use. Companies in the C Reactive Protein Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more